154 related articles for article (PubMed ID: 35061693)
1. Rational construction of controllable autoimmune diabetes model depicting clinical features.
Yu F; Zhou X; Jin X; Zhao S; Zhao G; Jiang S; Geng S; Wang B
PLoS One; 2022; 17(1):e0260100. PubMed ID: 35061693
[TBL] [Abstract][Full Text] [Related]
2. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas.
Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y
J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice.
Xiang Z; Ma LL; Manicassamy S; Ganesh BB; Williams P; Chari R; Chong A; Yin DP
Transplantation; 2008 Apr; 85(8):1205-11. PubMed ID: 18431243
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.
Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB
Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123
[TBL] [Abstract][Full Text] [Related]
5. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
[TBL] [Abstract][Full Text] [Related]
7. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.
Xiu Y; Wong CP; Bouaziz JD; Hamaguchi Y; Wang Y; Pop SM; Tisch RM; Tedder TF
J Immunol; 2008 Mar; 180(5):2863-75. PubMed ID: 18292508
[TBL] [Abstract][Full Text] [Related]
8. HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells.
Whitfield-Larry F; Young EF; Talmage G; Fudge E; Azam A; Patel S; Largay J; Byrd W; Buse J; Calikoglu AS; Shultz LD; Frelinger JA
Diabetes; 2011 Jun; 60(6):1726-33. PubMed ID: 21521873
[TBL] [Abstract][Full Text] [Related]
9. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
10. Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes.
Plesner A; Ten Holder JT; Verchere CB
PLoS One; 2014; 9(8):e102843. PubMed ID: 25101835
[TBL] [Abstract][Full Text] [Related]
11. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
[TBL] [Abstract][Full Text] [Related]
12. Effects of streptozotocin on autoimmune diabetes in NOD mice.
Koulmanda M; Qipo A; Auchincloss H; Smith RN
Clin Exp Immunol; 2003 Nov; 134(2):210-6. PubMed ID: 14616779
[TBL] [Abstract][Full Text] [Related]
13. Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage.
González-Mariscal I; Pozo-Morales M; Romero-Zerbo SY; Espinosa-Jimenez V; Escamilla-Sánchez A; Sánchez-Salido L; Cobo-Vuilleumier N; Gauthier BR; Bermúdez-Silva FJ
Biomed Pharmacother; 2022 Jan; 145():112361. PubMed ID: 34872800
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse.
Bobbala D; Chen XL; Leblanc C; Mayhue M; Stankova J; Tanaka T; Chen YG; Ilangumaran S; Ramanathan S
Diabetologia; 2012 Nov; 55(11):3010-20. PubMed ID: 22890824
[TBL] [Abstract][Full Text] [Related]
15. Recombinant
Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
[TBL] [Abstract][Full Text] [Related]
16. Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.
Di Lorenzo TP; Peakman M; Roep BO
Clin Exp Immunol; 2007 Apr; 148(1):1-16. PubMed ID: 17349009
[TBL] [Abstract][Full Text] [Related]
17. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
Pearson JA; Wong FS; Wen L
J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
[TBL] [Abstract][Full Text] [Related]
18. Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Frederick KE; Parvin CA; Plurad SB; Levisetti MG
Am J Pathol; 2003 Nov; 163(5):2077-91. PubMed ID: 14578206
[TBL] [Abstract][Full Text] [Related]
19. B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model.
Da Rosa LC; Boldison J; De Leenheer E; Davies J; Wen L; Wong FS
Diabetologia; 2018 Jun; 61(6):1397-1410. PubMed ID: 29594371
[TBL] [Abstract][Full Text] [Related]
20. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene.
Melanitou E
Gene; 2020 Aug; 753():144785. PubMed ID: 32445922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
